Benralizumab Initiated During Severe Asthma Attack

NCT04617171 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

128

Enrollment

OTHER

Sponsor class

Conditions

Asthma Attack
Asthma

Interventions

DRUG: Benralizumab 30 MG/ML [Fasenra]
DRUG: Placebos

Sponsor

Singapore General Hospital